When would you recommend adjuvant therapy for a patient with urethral adenocarcinoma after partial urethrectomy?

My first approach in this setting is to have the pathology reviewed by an expert tumor pathologist, and to be sure of the T stage, margins, N/M stage, and whether any tumor markers are heavily expressed. If there is a strongly expressed tumor marker, such as CEA, I will obtain baseline, and interval...

Treatment of urethral carcinoma varies depending on the gender of the patient, location, and histologic type. Because of rarity, there is a scarcity of data to guide treatment for patients with adenocarcinoma of urethra. Surgery alone is not adequate in most patients with locally advanced urethral c...